Activation of nuclear factor-kappa B by linear ubiquitin chain assembly complex contributes to lung metastasis of osteosarcoma cells.

NF-κB is involved in the metastasis of malignant cells. We have shown that NF-κB activation is involved in the pulmonary metastasis of LM8 cells, a highly metastatic subclone of Dunn murine osteosarcoma cells. Recently, it was determined that a newly identified type of polyubiquitin chain, a linear polyubiquitin chain, which is specifically generated by the linear ubiquitin chain assembly complex (LUBAC), plays a critical role in NF-κB activation. Here, we have evaluated the roles of LUBAC-mediated NF-κB activation in the development of lung metastasis of osteosarcoma cells. All three components of LUBAC (HOIL-1L, HOIP and SHARPIN) were highly expressed in LM8 cells compared to Dunn cells. Attenuation of LUBAC expression by stable knockdown of HOIL-1L in LM8 cells significantly suppressed NF-κB activity, invasiveness in vitro and lung metastasis. Induction of intracellular adhesion molecule-1 (ICAM-1) expression by LUBAC is involved in cell retention in the lungs after an intravenous inoculation of tumor cells. Moreover, we found that knockdown of LUBAC decreased not only the number but also the size of the metastatic nodules of LM8 cells in the lungs. These results indicate that LUBAC-mediated NF-κB activation plays crucial roles in several steps involved in metastasis, including extravasation and growth of osteosarcoma cells in the lung, and that suppression of LUBAC-mediated linear polyubiquitination activity may be a new approach to treat this life-threatening disease of young adolescents.

[1]  Anthony W. Purcell,et al.  Linear ubiquitination prevents inflammation and regulates immune signalling , 2011, Nature.

[2]  中川 朋子 Sharpin is a component of the NF-κB activating linear ubiquitin chain assembly complex , 2011 .

[3]  J. Sundberg,et al.  Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice. , 2011, The Journal of investigative dermatology.

[4]  Xijie Yu,et al.  Loss-of-function of SHARPIN causes an osteopenic phenotype in mice , 2010, Endocrine.

[5]  N. Naka,et al.  Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8 , 2010, Clinical & Experimental Metastasis.

[6]  S. Huh,et al.  Tumor and Stem Cell Biology Cancer Research Transiently Entrapped Circulating Tumor Cells Interact with Neutrophils to Facilitate Lung Metastasis Development , 2010 .

[7]  S. S. Koh,et al.  Newly identified tumor-associated role of human Sharpin , 2010, Molecular and Cellular Biochemistry.

[8]  S. Akira,et al.  Involvement of linear polyubiquitylation of NEMO in NF-κB activation , 2009, Nature Cell Biology.

[9]  S. Ferrari,et al.  High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions , 2008, Journal of surgical oncology.

[10]  A. Baldwin,et al.  Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer. , 2008, Cancer research.

[11]  C. Ware,et al.  The Lymphotoxin-β Receptor Is an Upstream Activator of NF-κB-mediated Transcription in Melanoma Cells* , 2008, Journal of Biological Chemistry.

[12]  A. Hoffmann,et al.  Negative regulation of constitutive NF‐κB and JNK signaling by PKN1‐mediated phosphorylation of TRAF1 , 2008, Genes to cells : devoted to molecular & cellular mechanisms.

[13]  Y. Toiyama,et al.  Soluble Intercellular Adhesion Molecule-1 as a Prognostic Marker for Stage II Colorectal Cancer Patients , 2008, Annals of Surgical Oncology.

[14]  Jan Delabie,et al.  Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma , 2008, Science.

[15]  M. Long,et al.  Two-dimensional kinetics of beta 2-integrin and ICAM-1 bindings between neutrophils and melanoma cells in a shear flow. , 2008, American journal of physiology. Cell physiology.

[16]  E. Lengyel,et al.  Thrombin Induces Tumor Invasion through the Induction and Association of Matrix Metalloproteinase-9 and β1-Integrin on the Cell Surface* , 2008, Journal of Biological Chemistry.

[17]  P. Lin,et al.  Endothelial cell adhesion molecules and cancer progression. , 2007, Current medicinal chemistry.

[18]  H. Yoshikawa,et al.  Parthenolide, a Natural Inhibitor of Nuclear Factor-κB, Inhibits Lung Colonization of Murine Osteosarcoma Cells , 2007, Clinical Cancer Research.

[19]  C. Shun,et al.  A Novel Anticancer Effect of Thalidomide: Inhibition of Intercellular Adhesion Molecule-1–Mediated Cell Invasion and Metastasis through Suppression of Nuclear Factor-κB , 2006, Clinical Cancer Research.

[20]  Keiji Tanaka,et al.  A ubiquitin ligase complex assembles linear polyubiquitin chains , 2006, The EMBO journal.

[21]  S. Ferrari,et al.  Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Hai-hong Lin,et al.  Experimental study of thalidomide for treatment of murine hepatocellular carcinoma. , 2005, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[23]  Stefan Kammerer,et al.  Role of ICAM1 in invasion of human breast cancer cells. , 2005, Carcinogenesis.

[24]  J. Jeekel,et al.  Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endothelium , 2004, International journal of cancer.

[25]  P. Picci,et al.  Activation of metalloproteinases-2 and -9 by interleukin-1alpha in S100A4-positive liposarcoma cell line: correlation with cell invasiveness. , 2004, Anticancer research.

[26]  Wei‐Chien Huang,et al.  Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel alpha-methylene-gamma-butyrolactone derivatives. , 2004, Carcinogenesis.

[27]  W. Winkelmann,et al.  Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Link,et al.  Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  丸尾 幸喜,et al.  ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer , 2003 .

[30]  H. Yoshikawa,et al.  VCP (p97) Regulates NFKB Signaling Pathway, Which Is Important for Metastasis of Osteosarcoma Cell Line , 2002, Japanese journal of cancer research : Gann.

[31]  A. Uchida,et al.  Transfection of Naked NF kappa B Decoy Oligodeoxynucleotide Suppresses Pulmonary Metastasis by Murine Osteosarcoma in the Alginate- encapsulated Tumor Spheroid Model , 2002 .

[32]  S. Philip,et al.  Osteopontin Stimulates Tumor Growth and Activation of Promatrix Metalloproteinase-2 through Nuclear Factor-κB-mediated Induction of Membrane Type 1 Matrix Metalloproteinase in Murine Melanoma Cells* , 2001, The Journal of Biological Chemistry.

[33]  R. Coffey,et al.  Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN , 2001, Oncogene.

[34]  R. Coffey,et al.  Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. , 2001, Oncogene.

[35]  Y. Liaw,et al.  Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. , 2000, Cancer.

[36]  V. Kähäri,et al.  Matrix metalloproteinases and their inhibitors in tumour growth and invasion. , 1999, Annals of medicine.

[37]  H. Pahl,et al.  Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.

[38]  H. Yoshikawa,et al.  Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung , 1998, International journal of cancer.

[39]  A. Palotie,et al.  Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C* , 1997, The Journal of Biological Chemistry.

[40]  P. Coffer,et al.  Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. , 1994, The Journal of biological chemistry.

[41]  T. Tötterman,et al.  Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. , 1994, Blood.

[42]  Y. Sasaguri,et al.  Production onf matrix metalloproteinase‐2 and metalloproteinase‐3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study , 1992, Cancer.

[43]  Y. Sasaguri,et al.  Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. , 1992, Cancer.

[44]  R. Rothlein,et al.  Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. , 1991, Cancer research.